Advance in recombinant adeno-associated virus mediated gene therapy for color blindness / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
; (12): 881-884, 2013.
Article
en Zh
| WPRIM
| ID: wpr-636225
Biblioteca responsable:
WPRO
ABSTRACT
Color blindness represents a group of vision disorders characterized by lack of ability to distinguish different colors.The inherited color blindness has been regarded as incurable for a long period of time.Recently,adeno-associated virus(AAV) mediated gene therapy has successfully restored cone system vision in animal models with color blindness caused by different gene mutations.These mutations are presented in human color blindness patients.It is predicted that gene therapy will become a novel treatment for these color blindness victims.In addition,a single gene transfer may achieve long-term correction of color deficiency.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Experimental Ophthalmology
Año:
2013
Tipo del documento:
Article